Ku86 is important for TrkA overexpression‐induced breast cancer cell invasion

Purpose: We have recently shown that breast tumors express high levels of TrkA compared with normal breast tissues, with TrkA overexpression enhancing breast cancer cell invasion in vitro and metastasis in animal models. In this study, we tried to identify molecules involved in TrkA overexpression‐mediated biological effects in breast cancer cells.

[1]  R. Toillon,et al.  TrkA overexpression enhances growth and metastasis of breast cancer cells , 2009, Oncogene.

[2]  S. Lees-Miller,et al.  Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. , 2009, The Biochemical journal.

[3]  A. Haas,et al.  Hdm2 is an Ubiquitin Ligase of Ku70 -Akt Promotes Cell Survival by Inhibiting Hdm2-dependent Ku70 Destabilization , 2008, Cell Death and Differentiation.

[4]  M. Miyazaki,et al.  Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase , 2008, Hepatology.

[5]  H. Hondermarck,et al.  Nerve growth factor is a potential therapeutic target in breast cancer. , 2008, Cancer research.

[6]  T. Morio,et al.  Ku, Artemis, and ataxia-telangiectasia-mutated: signalling networks in DNA damage. , 2008, The international journal of biochemistry & cell biology.

[7]  C. Muller,et al.  Transport of the leaderless protein Ku on the cell surface of activated monocytes regulates their migratory abilities , 2007, EMBO reports.

[8]  M. Giuffrida,et al.  Combined cup loading, bis(2‐hydroxyethyl) disulfide, and protein precipitation protocols to improve the alkaline proteome of Lactobacillus hilgardii , 2007, Electrophoresis.

[9]  D. Cao,et al.  Transforming growth factor-beta signaling in breast cancer. , 2007, Frontiers in bioscience : a journal and virtual library.

[10]  A. Theocharis,et al.  The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer. , 2007, Current medicinal chemistry.

[11]  A. Papatsoris,et al.  Manipulation of the nerve growth factor network in prostate cancer , 2007, Expert opinion on investigational drugs.

[12]  A. Selman,et al.  Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. , 2007, Gynecologic oncology.

[13]  W. Gullick,et al.  The Role of the Epidermal Growth Factor Receptor in Breast Cancer , 2006, Journal of Mammary Gland Biology and Neoplasia.

[14]  Y. Katayama,et al.  TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[15]  R. Bachelder,et al.  Non-Angiogenic Functions of VEGF in Breast Cancer , 2005, Journal of Mammary Gland Biology and Neoplasia.

[16]  Rogier Versteeg,et al.  Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. , 2005, Cancer letters.

[17]  J. Luk,et al.  Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma , 2005, Proteomics.

[18]  P. Jeggo,et al.  The life and death of DNA-PK , 2005, Oncogene.

[19]  B. Salles,et al.  The Double Life of the Ku Protein: Facing the DNA Breaks and the Extracellular Environment , 2005, Cell cycle.

[20]  C. Muller,et al.  The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9 , 2004, The EMBO journal.

[21]  H. Hondermarck,et al.  Nerve growth factor receptors and signaling in breast cancer. , 2004, Current cancer drug targets.

[22]  Hidde Ploegh,et al.  Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. , 2004, Molecular cell.

[23]  T. Rabilloud,et al.  Preparing Protein Extracts for Quantitative Two‐Dimensional Gel Comparison , 2003, Current protocols in protein science.

[24]  J. Nesland,et al.  Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  P. Lescuyer,et al.  A versatile electrophoresis system for the analysis of high‐ and low‐molecular‐weight proteins , 2003, Electrophoresis.

[26]  M. Sawada,et al.  Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70 , 2003, Nature Cell Biology.

[27]  P. Dobrzanski,et al.  The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Fengfei Wang,et al.  Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications. , 2002, Experimental hematology.

[29]  F. Amenta,et al.  Neurotrophins and neurotrophin receptors in human lung cancer. , 2001, American journal of respiratory cell and molecular biology.

[30]  A. Nakagawara,et al.  Trk receptor tyrosine kinases: a bridge between cancer and neural development. , 2001, Cancer letters.

[31]  M. Schnölzer,et al.  A new silver staining apparatus and procedure for matrix‐assisted laser desorption/ionization‐time of flight analysis of proteins after two‐dimensional electrophoresis , 2001, Proteomics.

[32]  J. Peyrat,et al.  Nerve Growth Factor Stimulates Proliferation and Survival of Human Breast Cancer Cells through Two Distinct Signaling Pathways* , 2001, The Journal of Biological Chemistry.

[33]  D. Faller,et al.  Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. , 2001, American journal of physiology. Cell physiology.

[34]  M. Gallucci,et al.  Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies , 2001, Oncogene.

[35]  A. Weeraratna,et al.  Rational basis for Trk inhibition therapy for prostate cancer , 2000, The Prostate.

[36]  D. Faller,et al.  Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). , 2000, Cancer letters.

[37]  O. Miera,et al.  Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair , 2000, Leukemia.

[38]  H. Friess,et al.  Nerve growth factor and its high-affinity receptor in chronic pancreatitis. , 1999, Annals of surgery.

[39]  H. Friess,et al.  Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  S. Baylin,et al.  Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  H. Hondermarck,et al.  Nerve Growth Factor Is Mitogenic for Cancerous but Not Normal Human Breast Epithelial Cells* , 1998, The Journal of Biological Chemistry.

[42]  J. Blanchard,et al.  Chromosomal location and expression of the genes coding for Ku p70 and p80 in human cell lines and normal tissues. , 1994, Cytogenetics and cell genetics.

[43]  S. Jhiang,et al.  Expression of the Ku protein during cell proliferation. , 1991, Biochimica et biophysica acta.

[44]  R. Kuick,et al.  Approach to stationary two‐dimensional pattern: Influence of focusing time and Immobiline/carrier ampholytes concentrations , 1988, Electrophoresis.

[45]  V. Neuhoff,et al.  Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.